Gene · 4734
Papers3,453
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,453
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin ligase Nedd4 regulates the abundance and toxicity of mutant huntingtin. | JCI Insight | 2026 | 41729074 | PubTator, text mining | PubMed |
| PFKP binding AMOTL1 promotes tumor aerobic glycolysis and epithelial-mesenchymal transition by modulating Hippo pathway in head and neck cancer. | J Transl Int Med | 2026 | 41727965 | PubTator, text mining | PubMed |
| Identification of Chondrocyte Stemness-Associated Biomarkers in Osteoarthritis Using Bioinformatics and Machine Learning Approaches. | J Inflamm Res | 2026 | 41709967 | PubTator, text mining | PubMed |
| The relationship between Connexin 43 (Cx43) and partner protein, human discs large homologue-1 (Dlg1) during wound closure in keratinocytes. | Cell Tissue Res | 2026 | 41703342 | PubTator, text mining | PubMed |
| Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1. | Acta Pharm Sin B | 2026 | 41685162 | PubTator, text mining | PubMed |
| LINE-1 Transcript Heterogeneity in Non-Small Cell Lung Cancers Is Driven by Host Genomic Context and Conserved Functional Hotspots. | Cancers (Basel) | 2026 | 41681929 | PubTator, text mining | PubMed |
| Negative regulation of the NF-κB pathway by the ubiquitin ligase Nedd4-1(NE). | Commun Biol | 2026 | 41654613 | PubTator, text mining | PubMed |
| Emerging biologic modalities for targeted protein degradation. | J Biol Chem | 2026 | 41651431 | PubTator, text mining | PubMed |
| HCV infection induces ubiquitin-dependent degradation of LATS1, inactivating the Hippo pathway and upregulating transcription of the CYR61 and CTGF genes. | J Gen Virol | 2026 | 41642640 | PubTator, text mining | PubMed |
| Lock, relax, load, and shoot: a molecular perspective on Nedd4 regulation. | FEBS J | 2026 | 41609434 | PubTator, text mining | PubMed |
| Starvation-induced NEDD4-mediated autophagy in BMSCs. | Biomed Rep | 2026 | 41607850 | PubTator, text mining | PubMed |
| Targeting GNG4 inhibits tumor progression and restores enzalutamide sensitivity in prostate cancer by suppressing autophagy. | Cell Death Dis | 2026 | 41605902 | PubTator, text mining | PubMed |
| Sec8: a novel positive regulator of RIG-I in anti-RNA viral defense. | Cell Death Dis | 2026 | 41580425 | PubTator, text mining | PubMed |
| Multivalent AMOTL1 Engages NEDD4-1 and KIBRA Through Distinct Cooperative Binding Mechanisms. | J Mol Biol | 2026 | 41580069 | PubTator, text mining | PubMed |
| Neural crest cell-derived DKK1 and NEDD4 modulate Wnt signalling in the second heart field to orchestrate outflow tract development. | Nat Commun | 2026 | 41571667 | PubTator, text mining | PubMed |
| Inpatient Admissions for Hypertensive Crises in the USA by Race and Gender: A Retrospective Study From the National Inpatient Sample From 2016 to 2022. | J Clin Hypertens (Greenwich) | 2026 | 41543283 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapeutic Potential of Degron-Mediated Proteostasis Regulation in Neurodegenerative Diseases. | Cell Mol Neurobiol | 2026 | 41528540 | PubTator, text mining | PubMed |
| A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy. | J Biol Chem | 2026 | 41525846 | PubTator, text mining | PubMed |
| NEDD4 promotes reactive astrogliosis by enhancing K63-linked ubiquitination and inhibiting chaperone-mediated autophagy degradation of YAP1. | Int J Biol Sci | 2026 | 41522361 | PubTator, text mining | PubMed |
| Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal clearance mechanism. | J Cell Biol | 2026 | 41498748 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4734/papers?page=3